全文获取类型
收费全文 | 1295篇 |
免费 | 103篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 68篇 |
妇产科学 | 37篇 |
基础医学 | 148篇 |
口腔科学 | 13篇 |
临床医学 | 194篇 |
内科学 | 243篇 |
皮肤病学 | 64篇 |
神经病学 | 117篇 |
特种医学 | 32篇 |
外科学 | 101篇 |
综合类 | 7篇 |
一般理论 | 2篇 |
预防医学 | 136篇 |
眼科学 | 13篇 |
药学 | 75篇 |
肿瘤学 | 143篇 |
出版年
2023年 | 12篇 |
2022年 | 13篇 |
2021年 | 32篇 |
2020年 | 26篇 |
2019年 | 44篇 |
2018年 | 50篇 |
2017年 | 33篇 |
2016年 | 41篇 |
2015年 | 49篇 |
2014年 | 51篇 |
2013年 | 68篇 |
2012年 | 96篇 |
2011年 | 94篇 |
2010年 | 56篇 |
2009年 | 55篇 |
2008年 | 78篇 |
2007年 | 98篇 |
2006年 | 79篇 |
2005年 | 60篇 |
2004年 | 70篇 |
2003年 | 75篇 |
2002年 | 66篇 |
2001年 | 9篇 |
2000年 | 9篇 |
1999年 | 13篇 |
1998年 | 14篇 |
1997年 | 16篇 |
1996年 | 10篇 |
1995年 | 2篇 |
1993年 | 8篇 |
1992年 | 5篇 |
1991年 | 6篇 |
1989年 | 2篇 |
1987年 | 5篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1983年 | 3篇 |
1982年 | 6篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1978年 | 2篇 |
1976年 | 4篇 |
1975年 | 5篇 |
1972年 | 2篇 |
1940年 | 2篇 |
1938年 | 2篇 |
1935年 | 1篇 |
1932年 | 1篇 |
1931年 | 2篇 |
排序方式: 共有1403条查询结果,搜索用时 796 毫秒
41.
Oon Hoe Teoh Tan Pih Lin Marieke Abrahamse-Berkeveld Antoinette Winokan Yap Seng Chong Fabian Yap Maya Marintcheva-Petrova Eline M. van der Beek Lynette P. Shek 《Nutrients》2022,14(3)
Lipids are essential for healthy infant growth and development. The structural complexity of lipids in human milk is not present in infant milk formula (IF). A concept IF was developed mimicking more closely the structure and composition of human milk fat globules. The current study evaluates whether a concept IF with large, milk phospholipid-coated lipid droplets (mode diameter 3 to 5 μm) is equivalent to standard IF with regard to growth adequacy and safety in healthy, term Asian infants. In this randomized, double-blind, controlled trial, infants were randomized after parents decided to introduce formula. Infants received a standard IF with (Control) or without the specific prebiotic mixture scGOS/lcFOS (9:1 ratio; Control w/o prebiotics), or a Concept IF with large, milk phospholipid-coated lipid droplets and the prebiotic mixture. A group of 67 breastfed infants served as a reference. As a priori defined, only those infants who were fully intervention formula-fed ≤28 days of age were included in the equivalence analysis (Control n = 29; Control w/o prebiotics n = 28; Concept n = 35, per-protocol population). Primary outcome was daily weight gain during the first four months of life, with the difference between the Concept and Control as the key comparison of interest. Additionally, adverse events, growth and tolerance parameters were evaluated. Equivalence of daily weight gain was demonstrated between the Concept and Control group after additional correction for ethnicity and birthweight (difference in estimated means of 0.1 g/d, 90%CI [−2.30, 2.47]; equivalence margin +/− 3 g/d). No clinically relevant group differences were observed in secondary growth outcomes, tolerance outcomes or number, severity or relatedness of adverse events. This study corroborates that an infant formula with large, milk phospholipid-coated lipid droplets supports adequate growth and is well tolerated and safe for use in healthy infants. 相似文献
42.
Inge A. Mulder MSc Mei Li PhD Tessa de Vries MSc Tao Qin Takeshi Yanagisawa MD PhD Kazutaka Sugimoto MD PhD Antoon van den Bogaerdt PhD A. H. Jan Danser MD PhD Marieke J. H. Wermer MD PhD Arn M. J. M. van den Maagdenberg PhD Antoinette MaassenVanDenBrink PhD Michel D. Ferrari MD PhD Cenk Ayata MD PhD 《Annals of neurology》2020,88(4):771-784
43.
Antoinette Burger Maritha J. Kotze Dan J. Stein Susan Janse van Rensburg Fleur M. Howells 《The European journal of neuroscience》2020,51(4):984-990
Fundamental human studies which address associations between glutamate and iron metabolism are needed. Basic research reports associations between glutamate and iron metabolism. Human studies report sex differences in iron metabolism and glutamate concentrations, which suggest that these relationships may differ by sex. We hypothesised associations would be apparent between in vivo glutamate and peripheral markers of iron metabolism, and these associations would differ by sex. To test this, we recruited 40 healthy adults (20 men, 20 women) and measured (a) standard clinical biomarker concentrations for iron metabolism and (b) an in vivo proxy for glutamate concentration, glutamate with glutamine in relation to total creatine containing metabolites using proton magnetic resonance spectroscopy studies with a two‐dimensional chemical shift imaging slice, with voxels located in bilateral dorsolateral prefrontal cortices, anterior cingulate cortices and frontal white matter. Only the female group reported significant associations between peripheral markers of iron metabolism and Glx:tCr concentration: (a) right dorsolateral prefrontal cortex Glx:tCr associated positively with serum transferrin (r = .60, p = .006) and negatively with transferrin saturation (r = ?.62, p = .004) and (b) right frontal white matter Glx:tCr associated negatively with iron concentration (r = ?.59, p = .008) and transferrin saturation (r = ?.65, p = .002). Our results support associations between iron metabolism and our proxy for in vivo glutamate concentration (Glx:tCr). These associations were limited to women, suggesting a stronger regulatory control between iron and glutamate metabolism. These associations support additional fundamental research into the molecular mechanisms of this regulatory control. 相似文献
44.
Anthony W. Tolcher Razelle Kurzrock Vincente Valero Rene Gonzalez Rebecca S. Heist Antoinette R. Tan Julie Means-Powell Theresa L. Werner Carlos Becerra Chenxi Wang Cathrine Leonowens Shanker Kalyana-Sundaram Joseph F. Kleha Jennifer Gauvin Anthony M. DAmelio Catherine Ellis Nageatte Ibrahim Li Yan 《Cancer chemotherapy and pharmacology》2020,85(4):673-683
This study aimed to determine the safety, tolerability, and recommended phase II doses of trametinib plus uprosertib (GSK2141795) in patients with solid tumors likely to be sensitive to MEK and/or AKT inhibition. This was a phase I, open-label, dose-escalation, and dose-expansion study in patients with triple-negative breast cancer or BRAF-wild type advanced melanoma. The primary outcome of the expansion study was investigator-assessed response. Among 126 enrolled patients, 63 received continuous oral daily dosing of trametinib and uprosertib, 29 received various alternative dosing schedules, and 34 were enrolled into expansion cohorts. Doses tested in the expansion cohort were trametinib 1.5 mg once daily (QD) + uprosertib 50 mg QD. Adverse events (AEs) were consistent with those reported in monotherapy studies but occurred at lower doses and with greater severity. Diarrhea was the most common dose-limiting toxicity; diarrhea and rash were particularly difficult to tolerate. Overall, 59% and 6% of patients reported AEs with a maximum severity of grade 3 and 4, respectively. Poor tolerability prevented adequate delivery of uprosertib with trametinib at a concentration predicted to have clinical activity. The study was terminated early based on futility in the continuous-dosing expansion cohorts and a lack of pharmacological or therapeutic advantage with intermittent dosing. The objective response rate was < 5% (1 complete response, 5 partial responses). Continuous and intermittent dosing of trametinib in combination with uprosertib was not tolerated, and minimal clinical activity was observed in all schedules tested. 相似文献
45.
Azoulay D Lucidi V Andreani P Maggi U Sebagh M Ichai P Lemoine A Adam R Castaing D 《Journal of the American College of Surgeons》2006,202(2):203-211
BACKGROUND: Two randomized prospective studies suggested that ischemic preconditioning (IP) protects the human liver against ischemia-reperfusion injury after hepatectomy performed under continuous clamping of the portal triad. The primary goal of this study was to determine whether IP protects the human liver against ischemia-reperfusion injury after hepatectomy under continuous vascular exclusion with preservation of the caval flow. STUDY DESIGN: Sixty patients were randomly divided into two groups: with (n=30; preconditioning group) and without (n=30; control group) IP (10 minutes of portal triad clamping and 10 minutes of reperfusion) before major hepatectomy under vascular exclusion of the liver preserving the caval flow. Serum concentrations of aspartate transferase, alanine transferase, glutathione-S-transferase, and bilirubin and prothrombin time were regularly determined until discharge and at 1 month. Morbidity and mortality were determined in both groups. RESULTS: Peak postoperative concentrations of aspartate transferase were similar in the groups with and without IP (851 +/- 1,733 IU/L and 427 +/- 166 IU/L respectively, p=0.2). A similar trend toward a higher peak concentration of alanine transferase and glutathione-S-transferase was indeed observed in the preconditioning group compared with the control group. Morbidity and mortality rates and lengths of ICU and hospitalization stays were similar in both groups. CONCLUSIONS: IP does not improve liver tolerance to ischemia-reperfusion after hepatectomy under vascular exclusion of the liver with preservation of the caval flow. This maneuver does not improve postoperative liver function and does not affect morbidity or mortality rates. The clinical use of IP through 10 minutes of warm ischemia in this technique of hepatectomy is not currently recommended. 相似文献
46.
Fleming SM Cumberledge B Kiesewetter C Parry G Kenny A 《The American journal of cardiology》2005,95(2):308-310
The determination of stroke volume (SV) is a potentially important application of real-time 3-dimensional echocardiography (RT3DE). SV measurements by thermodilution were compared with values obtained using transthoracic RT3DE in a sequential cohort of patients who underwent assessment for potential cardiac transplantation. There was a strong correlation between echocardiographically derived SV and catheterization data (r = 0.95, n = 14). On average, RT3DE appeared to underestimate SV by 7.5 ml (SD = 5.8) or 17% (SD = 12%). A role for RT3DE in the measurement of SV in severe heart failure is suggested. 相似文献
47.
48.
49.
50.
Desiré L. Dalton Anna M. van Wyk Antoinette Kotzé 《Conservation Genetics Resources》2011,3(4):677-679
Eight microsatellite markers were developed via pyrosequencing for the blesbok (Damaliscus pygargus phillipsi). These microsatellite loci and microsatellite loci from two cross species markers displayed two to four alleles with an expected heterozygosity range between 0.2899 and 0.6268 and an observed heterozygosity between 0.2083 and 0.6667. The high level of polymorphisms observed in the microsatellite markers indicates that they can be used to strongly improve our knowledge of the genetic structure and relatedness of these animals. 相似文献